β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells

Area of Science:

• Molecular oncology
• Cancer cell biology
• Protein-protein interactions

Background:

• Loss of promyelocytic leukemia protein (PML) nuclear body (NB) formation is observed in various solid tumors, including colorectal cancer.
• The precise mechanisms underlying PML function loss in cancer, despite rare genetic alterations in PML, remain largely unknown.

Purpose of the Study:

• To investigate the role of beta-catenin in the disruption of PML nuclear body formation in colorectal cancer cells.
• To elucidate the molecular mechanisms by which beta-catenin influences PML function and localization.

Main Methods:

• Utilized mass spectrometry to identify proteins interacting with T-cell factor 4 in colorectal cancer cell lines.
• Investigated the effects of beta-catenin expression levels on PML function and PML nuclear body assembly.
• Examined the interaction between beta-catenin and PML isoform IV, focusing on SUMOylation processes.

Main Results:

• Identified a specific interaction between beta-catenin and the PML isoform IV (PML-IV).
• Demonstrated that beta-catenin overexpression disrupts PML-IV compartmentalization and PML-NB formation in colorectal cancer cells.
• Showed that beta-catenin inhibits Ran-binding protein 2-mediated SUMOylation of PML-IV, a process crucial for PML-NB assembly.

Conclusions:

• Beta-catenin directly interacts with PML-IV, leading to the disruption of PML-NB formation via inhibition of PML-IV SUMOylation.
• This study reveals a posttranslational mechanism contributing to PML-NB disorganization in cancer.
• Findings provide new insights into the oncogenic functions of beta-catenin related to nuclear body organization.